Scott L Pescatore | Oncology General Manager. Rare Diseases

Scott L Pescatore, Oncology General Manager. Rare Diseases, Novartis

Scott Pescatore has dedicated the past 20 years of his career to the field of oncology across a broad range of medical and commercial activities in the US and Europe.  He has a passion for innovation and improving and extending patient’s lives, particularly in the area of rare diseases.  Scott has worked for Novartis Oncology since 2001 across roles of increasing responsibility and is currently the European general manager for the rare disease business unit where he is responsible for a portfolio of products focused on providing solutions to patients suffering from rare and difficult to treat conditions. 
Scott holds a Doctoral degree in Pharmacology and was a Post-Doctoral Fellow in Drug Development at the University of North Carolina Chapel Hill and GlaxoSmithKline.


Day 2 Orphan 15th Nov @ 08:35

Executive industry discussion: Intentions of pharmaceutical companies developing treatments for rare disease patients – What do they hope to achieve?

  • The evolving role of pharma and multi-stakeholders
  • What are the challenges?
  • What are the options moving forward?
  • How do we work together to improve this?

back to speakers